Urapidil

Overview

Urapidil is an α1 adrenoreceptor antagonist and a 5-HT 1A receptor agonist that can cross the blood-brain barrier.

Application

Products | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Depression | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Hypertension | Products > Disease Areas > Obesity | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > 5-HT Receptor | Products > Signaling Pathways > Adrenergic Receptor

Product Information

• Catalog No.: HY-B0716
• CAS No.: 34661-75-1
• Molecular Formula: C20H29N5O3
• Molecular Weight: 387.48
• Purity: 99.30%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (6.45 mM); Clear solution
• Availability: In-stock

Source

Original product source